Celularity Inc
For the period ended Mar 31, 2025. Filed Aug 29, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed Aug 29, 2025
CELU$0.71-6.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Condensed Consolidated Balance Sheets
(In thousands, except share and per share amounts)
| March 31, 2025 | December 31, 2024 | |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $293 | $738 |
| Accounts receivable, net of allowance of $6,233 and $6,294 as of March 31, 2025 and December 31, 2024, respectively | 14,968 | 13,557 |
| Inventory | 6,197 | 5,409 |
| Prepaid expenses and other current assets | 622 | 857 |
| Total current assets | 22,080 | 20,561 |
| Noncurrent assets: | ||
| Property and equipment, net | 60,134 | 61,600 |
| Goodwill | 7,347 | 7,347 |
| Intangible assets, net | 8,880 | 9,248 |
| Right-of-use assets - operating leases | 10,798 | 10,830 |
| Restricted cash | 10,011 | 10,239 |
| Inventory, net of current portion | 9,372 | 12,587 |
| Other noncurrent assets | 254 | 270 |
| Total assets | $128,876 | $132,682 |
| Liabilities and Stockholders’ (Deficit) Equity | ||
| Current liabilities: | ||
| Accounts payable | $23,313 | $23,296 |
| Accrued expenses and other current liabilities | 25,248 | 19,842 |
| Acquisition-related contingent consideration | — | 650 |
| Short-term debt - unaffiliated | 2,492 | 2,485 |
| Short-term debt - related parties | 4,161 | 3,876 |
| Deferred revenue | 3,476 | 3,531 |
| Total current liabilities | 58,690 | 53,680 |
| Noncurrent liabilities: | ||
| Deferred revenue, net of current portion | 2,804 | 2,724 |
| Acquisition-related contingent consideration, net of current portion | 1,413 | 1,413 |
| Long-term debt - related parties | 36,492 | 35,927 |
| Long-term lease liabilities | 26,631 | 26,548 |
| Warrant liabilities | 8,067 | 3,264 |
| Deferred income tax liabilities | 9 | 9 |
| Other liabilities | 276 | 280 |
| Total liabilities | 134,382 | 123,845 |
| Commitments and Contingencies (Note 12) | - | - |
| Stockholders’ (deficit) equity: | ||
| Preferred stock, $0.0001 par value, 10,000,000 shares authorized, none issued and outstanding as of March 31, 2025 and December 31, 2024, respectively | — | — |
| Common stock, $0.0001 par value, 730,000,000 shares authorized, 23,944,084 and 22,546,671 issued and outstanding as of March 31, 2025 and December 31, 2024, respectively | 2 | 2 |
| Additional paid-in capital | 913,993 | 908,523 |
| Accumulated deficit | (919,501) | (899,683) |
| Accumulated other comprehensive loss | — | (5) |
| Total stockholders’ (deficit) equity | (5,506) | 8,837 |
| Total liabilities and stockholders’ (deficit) equity | $128,876 | $132,682 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.